Continuous subcutaneous levetiracetam in end-of-life care

Pages: bcr - 222340
Published: Jan 18, 2018
Abstract
Seizures constitute a determining aspect in quality of life and are frequently challenging in palliative care—a field where treatment has yet to be standardised. Levetiracetam—a new generation anticonvulsant—has proved efficacy both through oral, as well as intravenous administration in the general population. This case reports on the use of continuous subcutaneous levetiracetam to effectively control seizures in a terminally ill patient without...
Paper Details
Title
Continuous subcutaneous levetiracetam in end-of-life care
Published Date
Jan 18, 2018
Journal
Pages
bcr - 222340
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.